Axsome Therapeutics Announces AXS-07 Phase 3 Migraine Trial Results Selected by the American Academy of Neurology Science Committee as Featured Presentation

Data from MOMENTUM Phase 3 trial to be presented at the 2020 AAN Science Highlights Platform